ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

DCCR Cancer Information Systems Program Renewed For Three More Years; Two Dropped, Two Added

September 1, 1978

Center Leaders Ok Consortium Center Guidelines, Go Along With Most Core Grant Changes Backed By NCI

April 19, 1985

Tamoxifen Makes ER-Negative Breast Cancer Easier To Find

October 31, 2008

Cancer Program Critics Called “Irresponsible,” Demagogues”

March 21, 1975

National Academy elects New Members

May 9, 1997

Entire Construction Budget In 1983 Goes to Two Grants; Help May Be On The Way

February 25, 1983